<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title><![CDATA[Forge Biologics 보도자료 - 뉴스와이어]]></title><link>https://www.newswire.co.kr/?md=A10&amp;act=article&amp;no=44670></link><description><![CDATA[Forge Biologics 보도자료 - 뉴스와이어 RSS 서비스]]></description><lastBuildDate>Thu, 14 May 2026 02:44:38 +0900</lastBuildDate><copyright>Copyright (c) 2004~2026 Korea Newswire All rights reserved</copyright><image><url><![CDATA[https://file.newswire.co.kr/data/upfile/company_img/2023/12/12_1028147215_20231213100802_7438090298.jpg]]></url></image><language>ko-KR</language><item><title><![CDATA[Forge Biologics Announces Publication in Human Gene Therapy on a Novel Finding That Changes a Fundamental Understanding of AAV Production]]></title><link>https://www.newswire.co.kr/newsRead.php?no=980894</link><description><![CDATA[COLUMBUS, Ohio--(Business Wire/Korea Newswire)--Forge Biologics (Forge), a leading manufacturer of genetic medicines, announced today the peer-reviewed publication of, “A novel role for the adenovirus L4 region 22K and 33K proteins in adeno-associated virus production,” in the research journal Human Gene Therapy. The article was authored by a team of molecular development scientists at Forge ...]]></description><pubDate>Wed, 13 Dec 2023 11:10:00 +0900</pubDate></item><item><title><![CDATA[포지 바이오로직스, 인간 유전자 치료에 대한 근본적인 이해를 바꾸는 새로운 발견에 관한 논문 발표]]></title><link>https://www.newswire.co.kr/newsRead.php?no=980895</link><description><![CDATA[콜럼버스, 오하이오--(Business Wire/뉴스와이어)--선도적인 유전자 의약품 제조업체인 포지 바이오로직스(Forge Biologics, 이하 ‘포지’)는 ‘아데노 관련 바이러스 생산에서 아데노 바이러스 L4 영역 22K 및 33K 단백질의 새로운 역할(A novel role for the adenovirus L4 region 22K and 33K proteins in adeno-associated virus production)’ 논문을 ‘인간 유전자 치료(Human Gene Therapy)’에 피어 리뷰(peer-reviewed)를...]]></description><pubDate>Wed, 13 Dec 2023 11:10:00 +0900</pubDate></item></channel></rss>